People

Mattias Ivarsson

biomedvc.comlinkedin.com

Mattias Ivarsson is an entrepreneur in residence at BiomedVC and founding CEO of Salvina Therapeutics. He previously founded Inositec during an ETH Zurich fellowship; that company was acquired by Vifor Pharma. He trained in biomedical engineering and pharmaceutical sciences and earned a doctorate at ETH Zurich. These are institutional manager affiliations; no personal portfolio investment is inferred.